Tacrolimus (FK506) 抗体
Our Local Distributor
北京 101111
Quick Overview for Tacrolimus (FK506) 抗体 (ABIN1722861)
抗原
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- Reacts with conjugated and non-conjugated FK-506 (Kd=10E-9M)
-
纯化方法
- Purified
-
免疫原
- FK-506 conjugated to bovine serum albumin.
-
亚型
- IgM
-
-
-
-
应用备注
- Working dilution: Optimal dilution should be determined by the end user.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- PBS, pH 7.4
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
注意事项
- Dilute in PBS or medium which is identical to that used in the assay system.
-
储存条件
- -20 °C
-
储存方法
- Stable for at least one year at -20°C. Avoid multiple freeze-thaw cycles.
-
有效期
- 12 months
-
-
- Tacrolimus (FK506)
-
别名
- FK-506
-
物质类
- Chemical
-
背景
-
FK-506 is a novel macrolide with similar, but more potent, immunosuppressant activity than cyclosporine. FK-506 is used for primary or rescue immunosuppression in patients after solid organ transplantation. Clinically relevant side effects of FK-506 administration are nephrotoxicity, neurotoxicity, diabetes mellitus, and hypertension. Most of these side effects are related to blood levels of FK-506 rather than dosage. Therefore, therapeutic drug monitoring of FK-506 is a prerequisite for therapy. The whole blood target level range aimed for in clinical practice is 3.0-20.0 ng/mL and depends on the patient's liver function, the nature of organ transplantation, and the time after transplantation.
Tacrolimus Fujimycin CAS : 109581-93-3 C44H69NO12 . H2O
抗原
-